← All organizations

Brightech International

For profit

Also known as: Brightech International

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

May 31, 2020

Timeline

2000s

Jun 1, 2002
Brightech International— Founded

Drugs by trial phase (1 distinct, 1 trials)

Phase 3 (1 own, 0 via acquisition)

interferon alpha-2b

Indications

Studied for

Recent trials (1)

NCT04285086CollaboratorPhase 3May 31, 2020

Details

Founded: Somerset, NJ, US Jun 1, 2002
Last known activity: May 31, 2020